References
- Mammucari M, Lazzari M, Maggiori E, Gafforio P, Tufaro G, Baffni S, et al. Role of the informed consent, from mesotherapy to opioid therapy. Eur Rev Med Pharmacol Sci. 2014;18(4):566–574.
- Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg. 2006;32(4):465–480.
- Mammucari M, Vellucci R, Mediati RD, Migliore A, Cuomo A, Maggiori E, et al. What is mesotherapy? Recommendations from an international consensus. Trends Med. 2014;14(1):1–10.
- Caruso MK, Roberts AT, Bissoon L, Self KS, Guillot TS, Greenway FL. An evaluation of mesotherapy solutions for inducing lipolysis and treating cellulite. J Plast Reconstr Aesthet Surg 2008;61(11):1321–1324.
- Kutlubay Z, Songür A, Engin B, Khatip R, Demirkesen C, Serdaroğlu S. Granulomatous reaction: a rare complication of mesotherapy. 9th World Congress of Cosmetic Dermatology. Athens, Greece27–30 June PP-16 (Poster)2013.
- Gokdemir G, Küçükünal A, Sakız D. Cutaneous granulomatous reaction from mesotherapy. Dermatol Surg. 2009;35(2):291–293.
- Mammucari M, Gatti A, Maggiori S, Bartoletti CA, Sabato AF. Mesotherapy, definition, rationale and clinical role: A consensus report from the Italian Society of Mesotherapy. Eur Rev Med Pharmacol Sci. 2011;15(6):682–694.
- Alfaro-Rubio A, Martorell-Calatayud A, Pelufo C, Terradez L, Hueso-Gabriel L, Garcia-Melgares ML. Mesotherapy granulomas with l-carnitine. American Academy of Dermatology 71st Annual Meeting. Florida, USA. 1–5 March 2013. PP-6919 (Poster).